Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present American Bio Medica Corp. (OTC: ABMC).

Full DD Report for ABMC

Recent News from (OTC: ABMC)

ABMC Reports Fourth Quarter and Year End 2017 Results
KINDERHOOK, NY / ACCESSWIRE / April 12, 2018 / American Bio Medica Corporation (OTC PINK: ABMC) today announced financial results for the fourth quarter and year ended December 31, 2017. Chief Executive Officer Melissa A. Waterhouse stated, "In the fourth quarter of 2017, we lost a signi...
Source: ACCESSWIRE
Date: April, 12 2018 15:50
ABMC Reports Third Quarter 2017 Results
American Bio Medica Corporation (OTCPK: ABMC) today announced financial results for the three and nine months ended September 30, 2017. Chief Executive Officer Melissa A. Waterhouse stated, “Although the third quarter of 2017 represented a decrease in sales when compared to the th...
Source: Business Wire
Date: November, 14 2017 10:00
FDA Grants OTC Clearance for ABMC's Rapid TOX CUP® II
American Bio Medica Corporation (OTCPK:ABMC) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) marketing clearance for over-the-counter use to the Company's Rapid TOX Cup II drug test product line. The Rapid TOX Cup II is an all-inclusive; one-step drug test...
Source: Business Wire
Date: August, 16 2017 11:16
ABMC Reports Second Quarter 2017 Results
American Bio Medica Corporation (OTCPK:ABMC) today announced financial results for the three and six months ended June 30, 2017. Chief Executive Officer Melissa A. Waterhouse stated, “Sales in the six months ended June 30, 2017 have been impacted by an anticipated decease in co...
Source: Business Wire
Date: August, 14 2017 11:11
ABMC Reports First Quarter 2017 Results
American Bio Medica Corporation (OTCPK: ABMC) today announced financial results for the three months ended March 31, 2017. Chief Executive Officer Melissa A. Waterhouse stated, “The new product and service offerings discussed in our March press release are now all available to our...
Source: Business Wire
Date: May, 15 2017 13:36
ABMC Reports Fourth Quarter and Year End 2016 Results
American Bio Medica Corporation (OTCPK:ABMC) today announced financial results for the fourth quarter and year ended December 31, 2016. Chief Executive Officer Melissa A. Waterhouse stated, “Organic growth continued to be challenging for ABMC in 2016 due to the continued price com...
Source: Business Wire
Date: March, 31 2017 09:30
American Bio Medica reports Q3 results
American Bio Medica ( OTCPK:ABMC ): Q3 EPS of $0.00 More news on: American Bio Medica Corp., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: November, 14 2016 10:06
ABMC Reports Third Quarter 2016 Results
American Bio Medica Corporation (OTCPK:ABMC) today announced financial results for the three and nine months ended September 30, 2016. Chief Executive Officer Melissa A. Waterhouse stated, “We are continuing to take steps to halt the sales declines we have been experiencing for so...
Source: Business Wire
Date: November, 14 2016 10:00
American Bio Medica reports Q2 results
American Bio Medica ( OTCPK:ABMC ): Q2 EPS of $0.00 Revenue of $1.5M (-11.2% Y/Y) Press Release More news on: American Bio Medica Corp., Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: August, 15 2016 11:48
ABMC Reports Second Quarter 2016 Results
American Bio Medica Corporation (OTCPK: ABMC) today announced financial results for the three and six months ended June 30, 2016. Chief Executive Officer Melissa A. Waterhouse stated, “New products and our ability to sell those products in new markets will be the primary future or...
Source: Business Wire
Date: August, 15 2016 11:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-04-210.090.090.090.09600
2018-04-200.090.090.090.09600
2018-04-190.090.110.110.092,400
2018-04-180.100.100.100.103,500
2018-04-17N/A0.09N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-04-20600600100.0000Short
2018-04-096,5006,500100.0000Short
2018-04-052,23155,0004.0564Cover
2018-04-0410,000105,7009.4607Cover
2018-04-031,0001,63261.2745Short

* Short Mode

Short Analysis provided by Squeeze Report.


About American Bio Medica Corp. (OTC: ABMC)

Logo for American Bio Medica Corp. (OTC: ABMC)

American Bio Medica Corporation is a biotechnology company that develops, manufactures and markets accurate, cost effective immunoassay test kits, including some of the world s most effective point of collection tests for drugs of abuse.

 

Contact Information

 

 

Current Management

  • Edmund Jaskiewicz / President
  • Douglas Casterlin / EVP, Ops.
  • Melissa Waterhouse / CCO, Vice President, Secretary
  • Edmund Jaskiewicz / Chairman

Current Share Structure

  • Market Cap: $3,222,707 - 03/16/2018
  • Authorized: 50,000,000 - 09/10/2009
  • Issue and Outstanding: 29,297,333 - 05/15/2017

 


Recent Filings from (OTC: ABMC)

Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 20 2018
Amendment to a previously filed Form 3
Filing Type: 3/AFiling Source: edgar
Filing Date: April, 19 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 12 2018
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 11 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 14 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 14 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 30 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 16 2017

 

 


Daily Technical Chart for (OTC: ABMC)

Daily Technical Chart for (OTC: ABMC)


Stay tuned for daily updates and more on (OTC: ABMC)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ABMC)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ABMC is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of ABMC and does not buy, sell, or trade any shares of ABMC. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/

 

 

Release this Report to Investors

Via Email

Via Text

Important

If you would like to schedule the release please Contact Us and we will assist you otherwise we will release this report to investors 15 minutes after payment is received to allow the most current information to be updated before the report is sent. Interested in reaching more investors? Contact Us